Study Questions Sole Focus on Weight Loss in GLP-1 Therapy Prescriptions

A JAMA research letter suggests GLP-1 therapies' emphasis on weight reduction may overlook broader health metrics. The study highlights that many online vendors prescribing GLP-1s rely on questionnaires with limited clinician engagement and infrequent requests for vital clinical values like blood pressure or cholesterol. This raises concerns about comprehensive patient care.